Kayt Sukel
Ozempic and other GLP-1 drugs are upending the food industry. Here’s what we can expect going forward
The use of anti-obesity medications (AOMs), led by glucagon-like peptide-1 (GLP-1) agonists like Ozempic (semaglutide), has skyrocketed over the past ...